In 2024, the MedChem Lab joined COST (European Cooperation in Science and technology)- Action CA23156, European Network for Sigma-1 Receptor as a Therapeutic Opportunity (SIGMA- EUROPE). This is a great opportunity for us for establishing new collaborations and widen our network.
In this context, we participate in the 5th European Symposium/1st Meeting of SIGMA-1 EUROPE, Granada, June 25-27, 2025 (https://sigma1europe.eu/) with three different contributions:
- Giacomo Rossino. Modulation of Sigma-1 receptor and TSPO through bivalent ligands: exploring a new approach against neuroinflammation and neurodegeneration.
- Sara Salvi RC-106, a promising therapeutic agent against glioblastoma. Scale up synthesis, solid-state characterization and in vivo evaluation.
- Daniela Rossi. Sigma-1 receptor: the hidden target of traditional preparations for neurodegeneration and neuropathic pain.